No meaningful health impacts from exposure to wind turbines
Peer-Reviewed Publication
Updates every hour. Last Updated: 31-May-2026 15:15 ET (31-May-2026 19:15 GMT/UTC)
A new study published in The Open Cardiovascular Medicine Journal has found that people newly diagnosed with atherosclerotic cardiovascular disease — a condition in which arteries narrow and harden due to chronic low-grade inflammation — ate significantly more fat and followed more inflammation-promoting dietary patterns than their healthy counterparts. Researchers from Hamadan University of Medical Sciences in Iran compared the diets and activity levels of 103 newly diagnosed atherosclerosis patients against 103 healthy individuals matched for age and sex. They found that patients consumed higher amounts of total fat, saturated fat, and unsaturated fats alike, while the healthy group ate more carbohydrates and dietary fiber. Notably, every single unit rise in the Dietary Inflammatory Index — a scientifically validated score that measures how much a person's diet promotes inflammation in the body — was associated with a 16.8% higher likelihood of developing the disease. The study was funded by Hamadan University of Medical Sciences (Grant Number 40376).
A small wool blanket wrapped around a baby who is stillborn or lost during pregnancy can make a significant difference in an acute situation of loss. This is shown in an artistic research dissertation from the University of Gothenburg.
Three faculty researchers from The University of Texas at San Antonio were celebrated with the inaugural Texas Innovation Award, a new statewide award recognizing leadership in translating academic research into real-world impact.
A phase 2 clinical trial showed burosumab, a targeted antibody therapy, safely restored phosphate balance in children and adults with fibrous dysplasia, a rare bone disorder associated with fractures and deformities. The therapy reduced abnormal bone turnover markers and improved mobility in severely affected children, including independent walking after full-time wheelchair use. The findings suggest that inhibition of fibroblast growth factor-23 may help reduce disability and improve physical function in patients with phosphate-wasting skeletal disease.